BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Personalized medicine
,
Valproic acid
,
rs7903146
,
PRKCA
,
Hepatitis
,
Leukocyte
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
adenosine a( 2b) receptor
Summary
General Info
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
Explore Curated Studies Results
Literature
Most Relevant Literature
Inhibitory effects of benzodiazepines on the adenosine A(2B) receptor mediated secretion of interleu…
Ligand-specific binding and activation of the human adenosine A(2B) receptor.
Role of adenosine A(2B) receptor stimulation in ischaemic postconditioning: dawn of a new paradigm i…
Contribution of adenosine A(2B) receptors in Clostridium difficile intoxication and infection.
Elevated ecto-5'-nucleotidase-mediated increased renal adenosine signaling via A2B adenosine recepto…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a…
Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participan…
Stress Testing and Cardiac Magnetic Resonance
A Study of ES014 (Anti-CD39/TGF-β Bispecific Antibody) in Patients With Locally Advanced or Metastat…
A Study of ES002023 (Anti-CD39 Antibody) in Patients With Locally Advanced or Metastatic Solid Tumor…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ